Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 76.24%153.42M | 139.22%236.38M | 215.00%121.81M | 241.25%398.64M | 175.33%166.39M | 53.38%87.05M | 4,583.39%98.81M | 910.95%38.67M | 33.62%116.82M | 147.30%60.43M |
| Net income from continuing operations | 1,444.71%262.46M | 9.26%30.04M | 79.71%-1.17M | 168.85%85.87M | 341.49%47.16M | 140.13%16.99M | 181.07%27.49M | 80.08%-5.77M | -191.62%-124.73M | 31.22%-19.53M |
| Operating gains losses | -74.83%3.47M | 225.82%10.69M | 354.05%16.08M | -345.22%-42.08M | -293.64%-41.03M | 259.42%13.77M | 85.11%-8.5M | -118.07%-6.33M | 94.21%-9.45M | -62.23%21.19M |
| Depreciation and amortization | 77.77%128.89M | 62.99%119.22M | 71.77%120.07M | 32.73%316.15M | 32.00%100.6M | 15.45%72.5M | 35.70%73.14M | 54.39%69.91M | 35.21%238.2M | 75.48%76.22M |
| Asset impairment expenditure | -19,573.70%-205M | 404.37%3.07M | 172.66%970K | 112.32%1.17M | 1,233.33%4.56M | 62.79%-1.04M | -668.70%-1.01M | -134.36%-1.34M | -80.35%552K | 66.67%-402K |
| Remuneration paid in stock | --0 | --0 | ---- | ---- | ---- | --0 | -112.32%-7.26M | ---- | ---- | ---- |
| Remuneration paid in stock | 80.66%7.42M | -20.04%3.66M | -41.59%4.16M | -15.74%16.01M | -93.73%205K | 208.95%4.11M | 91.50%4.58M | -40.70%7.13M | -40.15%19.01M | -86.20%3.27M |
| Deferred tax | 12.90%18.87M | 13.59%22.71M | 120.34%15.33M | 37.88%46.39M | 196.43%2.73M | -63.28%16.71M | 1,582.49%19.99M | 168.09%6.96M | -41.27%33.64M | 90.80%-2.83M |
| Other non cashItems | 1,253.92%31.76M | 1,931.47%37.01M | 2,717.31%34.99M | -95.55%3.2M | -94.55%1.63M | 120.00%2.35M | 82.89%-2.02M | -76.66%1.24M | 600.56%71.94M | 1,248.92%29.89M |
| Change In working capital | -162.33%-83.57M | 478.13%19.3M | -104.18%-46.04M | 96.47%-3.2M | 196.15%48.58M | -302.67%-31.86M | 62.61%-5.1M | 41.91%-22.55M | 3.38%-90.64M | -53.24%-50.53M |
| -Change in receivables | -127.24%-107.25M | 144.69%54.91M | -262.44%-67.47M | -124.33%-11.4M | 608.49%31.97M | -395.63%-47.2M | 69.88%22.44M | -177.70%-18.62M | 231.88%46.84M | 91.75%-6.29M |
| -Change in inventory | -80.01%-24.58M | -98.40%-25.72M | 80.02%-1.14M | -8,892.13%-40.02M | -360.26%-7.69M | -557.71%-13.65M | -176.41%-12.96M | 58.24%-5.71M | -100.82%-445K | -103.46%-1.67M |
| -Change in payables and accrued expense | 37.24%40.92M | -230.55%-5.4M | 452.77%19.09M | 117.20%17.41M | -56.49%-20M | 198.32%29.82M | 110.00%4.14M | 125.75%3.45M | -63.53%-101.23M | -318.15%-12.78M |
| -Change in other current assets | 509.17%3.26M | 55.57%-3.69M | 1,981.40%5.93M | 718.91%23.17M | 350.78%31.98M | -108.80%-796K | -58.79%-8.3M | 103.53%285K | 123.87%2.83M | 180.55%7.09M |
| -Change in other current liabilities | 14,667.86%4.08M | 92.29%-803K | -24.54%-2.45M | 119.75%7.63M | 133.39%12.32M | -100.12%-28K | -476.98%-10.42M | 92.89%-1.96M | -0.19%-38.63M | -1,652.21%-36.88M |
| Tax refund paid | -67.83%-10.88M | -272.73%-9.3M | -113.50%-22.59M | -14.59%-24.87M | -268.37%-5.31M | -110.05%-6.48M | -21.60%-2.49M | 46.34%-10.58M | 68.97%-21.7M | 141.31%3.16M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 76.24%153.42M | 139.22%236.38M | 215.00%121.81M | 241.25%398.64M | 175.33%166.39M | 53.38%87.05M | 4,583.39%98.81M | 910.95%38.67M | 33.62%116.82M | 147.30%60.43M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -5.70%-132.29M | 11.44%-122.05M | 8.46%-107.05M | 24.73%-506.77M | 13.11%-126.85M | 34.28%-125.17M | 9.29%-137.82M | 36.75%-116.94M | -81.60%-673.28M | 8.65%-146M |
| Net PPE purchase and sale | -24.80%-132.26M | -3.28%-122M | -10.27%-107.05M | 27.35%-448.03M | 4.10%-126.85M | 38.73%-105.98M | 13.86%-118.13M | 44.32%-97.07M | -10.18%-616.73M | 12.78%-132.27M |
| Net business purchase and sale | ---- | ---- | ---- | --70K | --0 | --70K | ---- | ---- | --0 | --0 |
| Net investment purchase and sale | ---- | ---- | ---- | -98.16%52K | ---- | ---- | ---- | ---- | 300.14%2.83M | 753.61%2.72M |
| Interest received (cash flow from investment activities) | --0 | --0 | --0 | 2.08%-60.26M | --0 | -10.29%-19.29M | -29.23%-19.72M | -72.78%-21.25M | -162.98%-61.54M | -88.61%-16.49M |
| Net other investing changes | -129.13%-30K | -288.46%-49K | ---- | -35.57%1.4M | -112.07%-123K | 1,960.00%103K | -94.38%26K | -21.57%1.39M | 128.85%2.17M | -123.48%-58K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -5.70%-132.29M | 11.44%-122.05M | 8.46%-107.05M | 24.73%-506.77M | 13.11%-126.85M | 34.28%-125.17M | 9.29%-137.82M | 36.75%-116.94M | -81.60%-673.28M | 8.65%-146M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -159.55%-22.48M | -420.08%-147.29M | 132.88%197.2M | -77.20%115.94M | -153.85%-44.79M | -73.47%37.75M | -73.06%46.02M | -23.18%84.68M | 164.64%508.47M | -24.51%83.17M |
| Net issuance payments of debt | -30.55%18.87M | -362.27%-132.73M | 219.08%231.36M | -139.95%-152.33M | -141.29%-23.82M | -75.36%27.18M | -59.79%50.61M | -322.24%-194.29M | 80.89%381.28M | -28.87%57.69M |
| Net common stock issuance | --0 | --0 | --0 | --252.95M | --2K | --0 | --0 | --252.95M | ---- | ---- |
| Cash dividends paid | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Proceeds from stock option exercised by employees | -71.82%454K | -90.84%131K | -82.06%115K | 38.50%3.77M | 138.14%90K | 2,883.33%1.61M | 168.29%1.43M | -72.96%641K | -12.53%2.72M | -138.31%-236K |
| Interest paid (cash flow from financing activities) | -2,717.32%-41.81M | -5,675.82%-30.09M | -433.40%-19.98M | -370.13%-30.99M | -733.42%-25.24M | 44.40%-1.48M | -30.90%-521K | -50.76%-3.75M | 13.21%-6.59M | 40.67%-3.03M |
| Net other financing activities | ---- | 380.02%15.4M | -149.10%-14.3M | -67.54%42.54M | -85.46%4.18M | -69.78%10.45M | -112.28%-5.5M | 27.07%29.13M | 1,025.73%131.06M | -14.35%28.74M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -159.55%-22.48M | -420.08%-147.29M | 132.88%197.2M | -77.20%115.94M | -153.85%-44.79M | -73.47%37.75M | -73.06%46.02M | -23.18%84.68M | 164.64%508.47M | -24.51%83.17M |
| Net cash flow | ||||||||||
| Beginning cash position | 125.46%310.8M | 162.28%343.67M | 4.43%131.59M | -26.01%126.02M | 7.64%137.78M | 18.70%137.85M | 31.69%131.03M | -26.01%126.02M | -35.02%170.31M | -34.17%128M |
| Current changes in cash | -273.55%-1.36M | -569.90%-32.95M | 3,205.68%211.96M | 116.27%7.81M | -118.92%-5.25M | -104.23%-363K | -57.91%7.01M | 109.05%6.41M | 47.37%-47.99M | 90.49%-2.4M |
| Effect of exchange rate changes | -158.90%-172K | 143.01%83K | 108.38%117K | -160.34%-2.23M | -327.49%-935K | -91.12%292K | -4,725.00%-193K | -23,383.33%-1.4M | 710.73%3.7M | -61.41%411K |
| End cash Position | 124.47%309.27M | 125.46%310.8M | 162.28%343.67M | 4.43%131.59M | 4.43%131.59M | 7.64%137.78M | 18.68%137.85M | 31.69%131.03M | -26.01%126.02M | -26.01%126.02M |
| Free cash from | 211.75%21.16M | 692.31%114.39M | 125.27%14.76M | 90.12%-49.39M | 155.03%39.53M | 83.71%-18.93M | 86.14%-19.31M | 65.75%-58.41M | -5.84%-499.91M | 43.53%-71.84M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.